Jeffrey T. Walsh serves as Executive at bluebird bio, Inc., where they oversee executive responsibilities. Since joining the company, Jeffrey T. Walsh has executed 201 insider transactions totaling $45.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 10, 2014 involved exercising options for 6,000 shares valued at $12.5K.
Jeffrey T. Walsh currently holds 41,421 shares of bluebird bio, Inc. (BLUE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey T. Walsh has been a net seller of BLUE stock. They have purchased $0 and sold $45.1M worth of shares.
Jeffrey T. Walsh's most recent insider trade was on Jan 10, 2014, when they sold 6,000 shares at $2.09 per share.
Get notified when new Form 4 filings are submitted